Why Dynavax Stock Is Skyrocketing 45.8% This Week
Shares of Dynavax Technologies (NASDAQ: DVAX) have skyrocketed 45.8% this week as of the market close on Thursday. Most of this big gain came after Dynavax's partner, Medigen, announced the launch of its COVID-19 vaccine MVC-COV1901 in Taiwan. Medigen's vaccine uses Dynavax's CpG 1018 adjuvant.
The rollout of MVC-COV1901 is off to a fast start. Medigen stated that around 600,000 people were expected to receive its vaccine this week.
Image source: Getty Images.
Source Fool.com
